Search results
Results From The WOW.Com Content Network
As with endometrial carcinomas, the prognosis is influenced by the grade and type of the adenocarcinoma, being poorest with serous differentiation. MMMTs are highly malignant; a stage I tumor has an expected five-year survival rate of 50%, while the overall five-year survival rate is less than 20%. [1] Staging of uterine MMMTs is as follows: [3]
Adenosarcoma (also Müllerian adenosarcoma) is a rare malignant tumor that occurs in women of all age groups, but most commonly post-menopause.Adenosarcoma arises from mesenchymal tissue and has a mixture of the tumoral components of an adenoma, a tumor of epithelial origin, and a sarcoma, a tumor originating from connective tissue.
A study of incidence rates in the US between 1992 and 1999 found that the age-specific incidence rate for HGSC doubles every 10 years up until age 55, where it plateaus at approximately 20 cases per 100,000 women - before dropping dramatically after age 75. [55] Ovarian cancer incidence rates are low in East Asia [56] and highest in Europe, the ...
Müllerian anomalies can be part of a multiple malformation syndrome. [1] [3] Studies have estimated that Mullerian anomalies can affect between 4 percent and nearly 7 percent of the female population. [4] [5] Müllerian anomalies occur as a congenital malformation of the Müllerian ducts during embryogenesis.
Krukenberg tumors are named after Friedrich Ernst Krukenberg (1871–1946), [11] who reported what he thought was a new type of primary ovarian malignancy in 1896; six years later these were shown to be of metastatic gastrointestinal tract origin. [7]
SRCC cancers are usually diagnosed during the late stages of the disease, so the tumors generally spread more aggressively than non-signet cancers, making treatment challenging. [19] In the future, case studies indicate that bone marrow metastases will likely play a larger role in the diagnosis and management of signet ring cell gastric cancer ...
The TNM Classification of Malignant Tumors (TNM) is a globally recognised standard for classifying the anatomical extent of the spread of malignant tumours (cancer). It has gained wide international acceptance for many solid tumor cancers, but is not applicable to leukaemia or tumors of the central nervous system .
The American Fertility Society (now American Society of Reproductive Medicine) Classification distinguishes: Class I—Müllerian agenesis (absent uterus). This condition is represented by the hypoplasia or the agenesis (total absence) of the different parts of the uterus: Vaginal hypoplasia or agenesis; Cervical hypoplasia or agenesis